Multi-channel intake
Cases from email, web forms, call notes, partners and literature collected into one queue with duplicate checks.
Drug-safety case management for marketing authorisation holders, CROs and PV service providers — from the first report to the regulatory submission.
Bright Infonet is a Panchkula-based software company that builds pharmacovigilance software: case intake from email, forms and literature, MedDRA coding, medical review, E2B(R3) ICSR generation and submission, and signal management. Part 11 audit trails and e-signatures are built in, and AI can pre-read each case so safety staff review instead of retyping.
Pharmacovigilance is a race against regulatory clocks. Every adverse event report has to be received, checked for validity, coded, assessed and, where required, submitted within a fixed number of days. When cases arrive in inboxes, PDFs and spreadsheets, staff spend their time copying data rather than assessing it.
Our PV software brings intake into one queue, tracks the due date of every case from day zero, and moves it through data entry, MedDRA coding, quality check, medical review and submission. Cases are exported as E2B(R3) ICSR files for the gateways and partners you report to, and periodic data is ready for aggregate reports.
We know this domain because we built PVgenix, our pharmacovigilance SaaS, where AI pre-reads each incoming case and pre-fills the fields for a person to confirm. You can see it described on our work page. For your own system, we reuse that experience in a build shaped around your SOPs.
Cases from email, web forms, call notes, partners and literature collected into one queue with duplicate checks.
Minimum criteria checked, seriousness and expectedness assessed, and the reporting clock started on day zero.
Events and indications coded with your licensed MedDRA version, and products against your product dictionary.
Second-person data checks and medical assessment with causality, narrative and electronic sign-off.
ICSR XML generated and validated against the E2B(R3) format, with acknowledgements tracked per receiver.
Follow-up information versioned against the original case, with resubmission when the changes require it.
Every open case with its regulatory deadline, so late submissions are prevented rather than explained.
Case series, disproportionality views and a tracked process for validating, prioritising and closing signals.
Line listings and summary tabulations for periodic reports, drawn from the same validated case data.
Every change to a case recorded with user, time and reason, and approvals signed electronically.
AI suggests fields and codes from source documents; a qualified person confirms every suggestion.
Case exchange with licensing partners and service providers under the timelines in your agreements.
It manages individual case safety reports from intake to regulatory submission: validity checks, coding, assessment, reporting deadlines, E2B files and audit trails. Many systems also support signal detection and aggregate reports.
E2B(R3) is the ICH standard for exchanging individual case safety reports electronically. Regulators such as the FDA and EMA accept ICSRs in this format through their gateways.
Yes. MedDRA is licensed through its maintenance organisation, so the subscription stays with your company. The software loads the version you are licensed for and handles version upgrades.
Yes, as an assistant. AI can read source documents and suggest case fields and codes, but a qualified person must review and confirm, and the system must log what the AI suggested.
Buy when a commercial safety database fits your volume and budget; build when your process, partners or cost structure do not fit. Our build-or-buy guide walks through the trade-offs.
We deliver it with a GAMP 5 validation pack and Part 11 controls. Your QA reviews, executes where required and approves the validated state.